Share on StockTwits
 

Research analysts at Credit Suisse lifted their price objective on shares of Stryker Corp. (NYSE:SYK) from $77.00 to $84.00 in a report released on Monday, AnalystRatings.Net reports. Credit Suisse’s price objective indicates a potential upside of 7.42% from the company’s current price.

A number of other analysts have also recently weighed in on SYK. Analysts at Barclays raised their price target on shares of Stryker Corp. from $76.00 to $79.00 in a research note to investors on Thursday, January 9th. They now have an “equal weight” rating on the stock. Separately, analysts at JPMorgan Chase & Co. raised their price target on shares of Stryker Corp. from $78.00 to $80.00 in a research note to investors on Wednesday, December 18th. Finally, analysts at TheStreet upgraded shares of Stryker Corp. from a “hold” rating to a “buy” rating in a research note to investors on Friday, December 6th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and nine have assigned a buy rating to the company. Stryker Corp. presently has a consensus rating of “Hold” and a consensus target price of $74.10.

Shares of Stryker Corp. (NYSE:SYK) opened at 78.20 on Monday. Stryker Corp. has a 52 week low of $61.19 and a 52 week high of $78.89. The stock has a 50-day moving average of $74.95 and a 200-day moving average of $71.55. The company has a market cap of $29.592 billion and a P/E ratio of 33.77.

The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of 0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 1.56%. The ex-dividend date of this dividend is Friday, December 27th. This is an increase from Stryker Corp.’s previous quarterly dividend of $0.27.

Stryker Corporation (NYSE:SYK) is a medical technology company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.